CIK 0001982708 · Non-accelerated filer<br>Emerging growth company
Anbio Biotechnology
Sign in to watch- Ticker
- NNNN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 4916096247281
- Business address
- FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, Germany, 60308
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| No insider trades stored. | ||||||